Literature DB >> 15270865

Th1 and Th2 cytokine production is suppressed at the level of transcriptional regulation in Kawasaki disease.

J Kimura1, H Takada, A Nomura, T Ohno, Y Mizuno, M Saito, K Kusuhara, T Hara.   

Abstract

To clarify the functional state of T cells in Kawasaki disease, we analysed mRNA expression levels of Th1/Th2 cytokines (IFN-gamma and IL-4) along with Th1/Th2-inducing transcription factors, T-bet and GATA-3, which play pivotal roles in the development of Th1 and Th2 cells, respectively. By real-time PCR, IFN-gamma mRNA levels in peripheral blood mononuclear cells (PBMNC) were significantly decreased in Kawasaki disease patients compared with those with measles, and tended to be lower than those in healthy controls. T-bet mRNA levels were significantly decreased in patients with Kawasaki disease compared with healthy controls. In addition, IL-4 and GATA-3 mRNA levels were significantly decreased in Kawasaki disease compared with healthy controls. Regulatory cytokine mRNA levels (TGF-beta and IL-10) were also decreased in Kawasaki disease. The mRNA levels of IFN-gamma showed a significant positive correlation with those of T-bet in Kawasaki disease. These results suggest that the suppressed function of Th1 and Th2, associated with the suppression of both T-bet and GATA-3 gene expression, may be one of the immunological characteristics of Kawasaki disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15270865      PMCID: PMC1809116          DOI: 10.1111/j.1365-2249.2004.02506.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

Review 1.  The lineage decisions of helper T cells.

Authors:  Kenneth M Murphy; Steven L Reiner
Journal:  Nat Rev Immunol       Date:  2002-12       Impact factor: 53.106

2.  T-bet expression is upregulated in active Behçet's disease.

Authors:  B Li; P Yang; H Zhou; Z Zhang; C Xie; X Lin; X Huang; A Kijlstra
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

Review 3.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

Review 4.  Pathological features of Kawasaki disease (mucocutaneous lymph node syndrome).

Authors:  B H Landing; E J Larson
Journal:  Am J Cardiovasc Pathol       Date:  1987

5.  Immunopathology of the skin lesion of Kawasaki disease.

Authors:  T Sugawara; S Hattori; S Hirose; S Furukawa; K Yabuta; T Shirai
Journal:  Prog Clin Biol Res       Date:  1987

6.  CTLA-4 (CD152) expression in peripheral blood T cells in Kawasaki disease.

Authors:  T Matsubara; R Anwar; M Fujiwara; T Ichiyama; S Furukawa
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

7.  Pathology of the heart in Kawasaki disease.

Authors:  H Fujiwara; Y Hamashima
Journal:  Pediatrics       Date:  1978-01       Impact factor: 7.124

8.  Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease.

Authors:  S Furukawa; T Matsubara; K Jujoh; K Yone; T Sugawara; K Sasai; H Kato; K Yabuta
Journal:  Clin Immunol Immunopathol       Date:  1988-08

9.  Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin.

Authors:  D Y Leung; J C Burns; J W Newburger; R S Geha
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

10.  The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease.

Authors:  M F Neurath; B Weigmann; S Finotto; J Glickman; E Nieuwenhuis; H Iijima; A Mizoguchi; E Mizoguchi; J Mudter; P R Galle; A Bhan; F Autschbach; B M Sullivan; S J Szabo; L H Glimcher; R S Blumberg
Journal:  J Exp Med       Date:  2002-05-06       Impact factor: 14.307

View more
  17 in total

1.  Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease.

Authors:  K Ikeda; K Yamaguchi; T Tanaka; Y Mizuno; A Hijikata; O Ohara; H Takada; K Kusuhara; T Hara
Journal:  Clin Exp Immunol       Date:  2009-12-15       Impact factor: 4.330

2.  Transforming growth factor-beta signaling pathway in patients with Kawasaki disease.

Authors:  Chisato Shimizu; Sonia Jain; Sonia Davila; Martin L Hibberd; Kevin O Lin; Delaram Molkara; Jeffrey R Frazer; Shelly Sun; Annette L Baker; Jane W Newburger; Anne H Rowley; Stanford T Shulman; Sonia Davila; David Burgner; Willemijn B Breunis; Taco W Kuijpers; Victoria J Wright; Michael Levin; Hariklia Eleftherohorinou; Lachlan Coin; Stephen J Popper; David A Relman; Wen Fury; Calvin Lin; Scott Mellis; Adriana H Tremoulet; Jane C Burns
Journal:  Circ Cardiovasc Genet       Date:  2010-12-02

3.  BTNL2 gene polymorphisms may be associated with susceptibility to Kawasaki disease and formation of coronary artery lesions in Taiwanese children.

Authors:  Kai-Chung Hsueh; Ying-Ju Lin; Jeng-Sheng Chang; Lei Wan; Fuu-Jen Tsai
Journal:  Eur J Pediatr       Date:  2009-11-01       Impact factor: 3.183

Review 4.  Regulatory T cells in cardiovascular diseases.

Authors:  Xiao Meng; Jianmin Yang; Mei Dong; Kai Zhang; Eric Tu; Qi Gao; Wanjun Chen; Cheng Zhang; Yun Zhang
Journal:  Nat Rev Cardiol       Date:  2015-11-03       Impact factor: 32.419

5.  Hospitalisation with infection, asthma and allergy in Kawasaki disease patients and their families: genealogical analysis using linked population data.

Authors:  Rebecca J Webster; Kim W Carter; Nicole M Warrington; Angeline M Loh; Sophie Zaloumis; Taco W Kuijpers; Lyle J Palmer; David P Burgner
Journal:  PLoS One       Date:  2011-11-28       Impact factor: 3.240

6.  Augmented TLR2 expression on monocytes in both human Kawasaki disease and a mouse model of coronary arteritis.

Authors:  I-Chun Lin; Ho-Chang Kuo; Ying-Jui Lin; Feng-Shen Wang; Lin Wang; Shun-Chen Huang; Shao-Ju Chien; Chien-Fu Huang; Chih-Lu Wang; Hong-Ren Yu; Rong-Fu Chen; Kuender D Yang
Journal:  PLoS One       Date:  2012-06-21       Impact factor: 3.240

7.  CD40 Gene polymorphisms associated with susceptibility and coronary artery lesions of Kawasaki disease in the Taiwanese population.

Authors:  Ho-Chang Kuo; Mei-Chyn Chao; Yu-Wen Hsu; Ying-Chi Lin; Ying-Hsien Huang; Hong-Ren Yu; Ming-Feng Hou; Chi-Di Liang; Kuender D Yang; Wei-Chiao Chang; Chih-Lu Wang
Journal:  ScientificWorldJournal       Date:  2012-05-02

Review 8.  Personalized exposure assessment: promising approaches for human environmental health research.

Authors:  Brenda K Weis; David Balshaw; John R Barr; David Brown; Mark Ellisman; Paul Lioy; Gilbert Omenn; John D Potter; Martyn T Smith; Lydia Sohn; William A Suk; Susan Sumner; James Swenberg; David R Walt; Simon Watkins; Claudia Thompson; Samuel H Wilson
Journal:  Environ Health Perspect       Date:  2005-07       Impact factor: 9.031

Review 9.  Understanding the pathogenesis of Kawasaki disease by network and pathway analysis.

Authors:  Yu-wen Lv; Jing Wang; Ling Sun; Jian-min Zhang; Lei Cao; Yue-yue Ding; Ye Chen; Ji-juan Dou; Jie Huang; Yi-fei Tang; Wen-tao Wu; Wei-rong Cui; Hai-tao Lv
Journal:  Comput Math Methods Med       Date:  2013-03-06       Impact factor: 2.238

10.  Plasma levels of monokine induced by interferon-gamma/chemokine (C-X-X motif) ligand 9, thymus and activation-regulated chemokine/chemokine (C-C motif) ligand 17 in children with Kawasaki disease.

Authors:  Siqi Feng; Shiv Kumar Yadav; Fang Gao; Qijian Yi
Journal:  BMC Pediatr       Date:  2015-09-03       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.